RxDoctor Payments Data

Deloris Ashlock Ruda

Family · Branson, MONPI 1770771636

Payments from drug & device makers

$2,901in general payments, 2019–2025

Across 168 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$711
  • Abbott$515
  • Lilly USA, LLC$403
  • Kowa Pharmaceuticals America, Inc.$358
  • Novo Nordisk$277
  • Dexcom, Inc.$218
  • plus $420 from 11 others

What the payments were for

  • Food & beverage$2,895100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,901 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide101$110,381
OzempicSemaglutide61$86,846
ProliaDenosumab42$72,623
EliquisApixaban33$36,652
TrulicityDulaglutide17$28,215
JardianceEmpagliflozin32$26,054
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$21,621
MyrbetriqMirabegron17$18,587
XareltoRivaroxaban17$16,970
VascepaIcosapent Ethyl68$16,769
Tresiba Flextouch U-200Insulin Degludec22$13,059
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$12,287
LivaloPitavastatin Calcium19$8,844
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,391
Tresiba Flextouch U-100Insulin Degludec13$7,147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$403$138,596118 claims
Novo NordiskOzempic$277$86,84661 claims
AmgenProlia$14$72,62342 claims
PfizerEliquis$142$36,65233 claims
Boehringer IngelheimJardiance$16$26,05432 claims
GSKTrelegy Ellipta$11$21,62133 claims
Johnson & JohnsonXarelto$16$16,97017 claims
AstraZenecaBreztri Aerosphere, Symbicort$711$14,45738 claims
Kowa Pharmaceuticals America, Inc.Livalo$358$8,84419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.

Other family in Branson

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →